Advertisement
Screener

Vivani Medical, Inc. (VANI) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

Vivani Medical, Inc. Research and Development Expense

Vivani Medical, Inc. (VANI) reported Research and Development Expense of $4.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13

  • Vivani Medical, Inc. research and development expense for the quarter ending 2026-06-30 was $4.46M, a 6.37% decline year-over-year.
  • Vivani Medical, Inc. research and development expense for the quarter ending 2026-03-31 was $4.39M, a 4.10% increase year-over-year.
  • Vivani Medical, Inc. research and development expense for the quarter ending 2025-12-31 was $4.63M, a 7.60% increase year-over-year.
  • Vivani Medical, Inc. research and development expense for the quarter ending 2025-09-30 was $4.52M, a 7.52% increase year-over-year.
  • Vivani Medical, Inc. research and development expense for fiscal 2025 was $18.13M, a 15.12% increase from fiscal 2024.
  • Vivani Medical, Inc. research and development expense for fiscal 2024 was $15.74M, a 7.21% decline from fiscal 2023.
  • Vivani Medical, Inc. research and development expense for fiscal 2023 was $16.97M, a 19.75% increase from fiscal 2022.
  • Vivani Medical, Inc. research and development expense for fiscal 2022 was $14.17M, a 28.79% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-06-30$4.46M
10-Q · filed 2026-08-13
$8.96M
10-Q · filed 2026-08-13
$13.48M
derived: sum of 3 quarters · filed 2026-08-13
$18.00M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$4.39M
10-Q · filed 2026-05-13
$9.02M
derived: sum of 2 quarters · filed 2026-05-13
$13.54M
derived: sum of 3 quarters · filed 2026-05-13
$18.30M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$4.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$9.15M
derived: sum of 2 quarters · filed 2026-03-26
$13.91M
derived: sum of 3 quarters · filed 2026-08-13
$18.13M
10-K · filed 2026-03-26
2025-09-30$4.52M
10-Q · filed 2025-11-13
$9.28M
derived: sum of 2 quarters · filed 2026-08-13
$13.50M
10-Q · filed 2025-11-13
$17.80M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$4.76M
10-Q · filed 2026-08-13
$8.98M
10-Q · filed 2026-08-13
$13.28M
derived: sum of 3 quarters · filed 2026-08-13
$17.48M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$4.22M
10-Q · filed 2026-05-13
$8.52M
derived: sum of 2 quarters · filed 2026-05-13
$12.72M
derived: sum of 3 quarters · filed 2026-05-13
$16.24M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$8.51M
derived: sum of 2 quarters · filed 2026-03-26
$12.02M
derived: sum of 3 quarters · filed 2026-03-26
$15.74M
10-K · filed 2026-03-26
2024-09-30$4.20M
10-Q · filed 2025-11-13
$7.72M
derived: sum of 2 quarters · filed 2025-11-13
$11.44M
10-Q · filed 2025-11-13
$16.15M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$3.51M
10-Q · filed 2025-08-13
$7.24M
10-Q · filed 2025-08-13
$11.95M
derived: sum of 3 quarters · filed 2025-08-13
$16.39M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$3.73M
10-Q · filed 2025-05-13
$8.43M
derived: sum of 2 quarters · filed 2025-05-13
$12.88M
derived: sum of 3 quarters · filed 2025-05-13
$16.74M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$4.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$9.15M
derived: sum of 2 quarters · filed 2025-03-31
$13.01M
derived: sum of 3 quarters · filed 2025-03-31
$16.97M
10-K · filed 2025-03-31
2023-09-30$4.44M
10-Q · filed 2024-11-13
$8.30M
derived: sum of 2 quarters · filed 2024-11-13
$12.26M
10-Q · filed 2024-11-13
$16.69M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$3.86M
10-Q · filed 2024-08-13
$7.82M
10-Q · filed 2024-08-13
$12.25M
derived: sum of 3 quarters · filed 2024-08-13
$16.11M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$3.96M
10-Q · filed 2024-05-13
$8.38M
derived: sum of 2 quarters · filed 2024-05-13
$12.24M
derived: sum of 3 quarters · filed 2024-05-13
$15.44M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31$4.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$8.29M
derived: sum of 2 quarters · filed 2024-03-26
$11.49M
derived: sum of 3 quarters · filed 2024-03-26
$14.17M
10-K · filed 2024-03-26
2022-09-30$3.86M
10-Q · filed 2023-11-13
$3.85M
10-Q · filed 2022-11-14
$7.06M
derived: sum of 2 quarters · filed 2023-11-13
$9.74M
10-Q · filed 2023-11-13
$9.74M
10-Q · filed 2022-11-14
$12.72M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$3.20M
10-Q · filed 2023-08-14
$843.00K
10-Q · filed 2022-08-12
$5.88M
10-Q · filed 2023-08-14
$1.49M
10-Q · filed 2022-08-12
$8.86M
derived: sum of 3 quarters · filed 2023-08-14
$11.72M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$2.68M
10-Q · filed 2023-05-15
$645.00K
10-Q · filed 2022-05-16
$5.65M
derived: sum of 2 quarters · filed 2023-05-15
$8.52M
derived: sum of 3 quarters · filed 2023-05-15
$9.22M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$2.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$5.84M
derived: sum of 2 quarters · filed 2023-03-31
$6.54M
derived: sum of 3 quarters · filed 2023-03-31
$11.00M
10-K · filed 2023-03-31
$2.37M
10-K · filed 2022-03-29
2021-09-30$2.87M
10-Q · filed 2022-11-14
$697.00K
10-Q · filed 2021-11-12
$3.56M
derived: sum of 2 quarters · filed 2022-11-14
$8.03M
10-Q · filed 2022-11-14
$1.73M
10-Q · filed 2021-11-12
$4.24M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$695.00K
10-Q · filed 2022-08-12
$1.03M
10-Q · filed 2022-08-12
$1.38M
derived: sum of 3 quarters · filed 2022-08-12
$1.66M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$334.00K
10-Q · filed 2022-05-16
$681.00K
derived: sum of 2 quarters · filed 2022-05-16
$960.00K
derived: sum of 3 quarters · filed 2022-05-16
$1.28M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$347.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$626.00K
derived: sum of 2 quarters · filed 2022-03-29
$949.00K
derived: sum of 3 quarters · filed 2022-03-29
$4.84M
10-K · filed 2022-03-29
2020-09-30$279.00K
10-Q · filed 2021-11-12
$602.00K
derived: sum of 2 quarters · filed 2021-11-12
$4.49M
10-Q · filed 2021-11-12
$8.63M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$323.00K
10-Q · filed 2021-08-13
$4.21M
10-Q · filed 2021-08-13
$8.36M
derived: sum of 3 quarters · filed 2021-08-13
$11.73M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$3.89M
10-Q · filed 2021-05-13
$8.03M
derived: sum of 2 quarters · filed 2021-05-13
$11.41M
derived: sum of 3 quarters · filed 2021-05-13
$14.85M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$4.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$7.52M
derived: sum of 2 quarters · filed 2021-03-16
$10.96M
derived: sum of 3 quarters · filed 2021-03-16
$13.14M
10-K · filed 2021-03-16
2019-09-30$3.38M
10-Q · filed 2020-11-12
$6.82M
derived: sum of 2 quarters · filed 2020-11-12
$9.00M
10-Q · filed 2020-11-12
$11.44M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$3.44M
10-Q · filed 2020-08-13
$5.62M
10-Q · filed 2020-08-13
$8.06M
derived: sum of 3 quarters · filed 2020-08-13
$10.73M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$2.18M
10-Q · filed 2020-06-26
$4.62M
derived: sum of 2 quarters · filed 2020-06-26
$7.29M
derived: sum of 3 quarters · filed 2020-06-26
$9.71M
derived: sum of 4 quarters · filed 2020-06-26
2018-12-31$2.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
$5.11M
derived: sum of 2 quarters · filed 2020-03-19
$7.53M
derived: sum of 3 quarters · filed 2020-03-19
$10.01M
10-K · filed 2020-03-19
2018-09-30$2.67M
10-Q · filed 2019-11-14
$5.09M
derived: sum of 2 quarters · filed 2019-11-14
$7.57M
10-Q · filed 2019-11-14
$9.84M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$2.42M
10-Q · filed 2019-08-06
$4.89M
10-Q · filed 2019-08-06
$7.17M
derived: sum of 3 quarters · filed 2019-08-06
$8.99M
derived: sum of 4 quarters · filed 2019-08-06
2018-03-31$2.47M
10-Q · filed 2019-05-15
$4.75M
derived: sum of 2 quarters · filed 2019-05-15
$6.57M
derived: sum of 3 quarters · filed 2019-05-15
$8.52M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$2.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19
$4.10M
derived: sum of 2 quarters · filed 2019-03-19
$6.05M
derived: sum of 3 quarters · filed 2019-03-19
$7.89M
10-K · filed 2019-03-19
2017-09-30$1.83M
10-Q · filed 2018-11-08
$3.77M
derived: sum of 2 quarters · filed 2018-11-08
$5.62M
10-Q · filed 2018-11-08
$7.70M
derived: sum of 4 quarters · filed 2019-03-19
2017-06-30$1.95M
10-Q · filed 2018-08-07
$3.80M
10-Q · filed 2018-08-07
$5.88M
derived: sum of 3 quarters · filed 2019-03-19
$7.46M
derived: sum of 4 quarters · filed 2019-03-19
2017-03-31$1.85M
10-Q · filed 2018-05-15
$3.93M
derived: sum of 2 quarters · filed 2019-03-19
$5.52M
derived: sum of 3 quarters · filed 2019-03-19
$6.43M
derived: sum of 4 quarters · filed 2019-03-19
2016-12-31$2.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19
$3.67M
derived: sum of 2 quarters · filed 2019-03-19
$4.58M
derived: sum of 3 quarters · filed 2019-03-19
$5.35M
10-K · filed 2019-03-19
2016-09-30$1.59M
10-Q · filed 2017-11-06
$2.50M
derived: sum of 2 quarters · filed 2017-11-06
$3.27M
10-Q · filed 2017-11-06
$3.81M
derived: sum of 4 quarters · filed 2018-03-20
2016-06-30$916.00K
10-Q · filed 2017-08-07
$1.68M
10-Q · filed 2017-08-07
$2.22M
derived: sum of 3 quarters · filed 2018-03-20
$2.82M
derived: sum of 4 quarters · filed 2018-03-20
2016-03-31$762.00K
10-Q · filed 2017-05-09
$762.00
10-Q · filed 2016-05-06
$1.31M
derived: sum of 2 quarters · filed 2018-03-20
$1.90M
derived: sum of 3 quarters · filed 2018-03-20
$2.75M
derived: sum of 4 quarters · filed 2018-03-20
2015-12-31$546.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20
$1.14M
derived: sum of 2 quarters · filed 2018-03-20
$1.99M
derived: sum of 3 quarters · filed 2018-03-20
$3.04M
10-K · filed 2018-03-20
2015-09-30$593.00K
10-Q · filed 2016-11-04
$592.82K
10-Q · filed 2015-11-16
$1.44M
derived: sum of 2 quarters · filed 2016-11-04
$2.49M
10-Q · filed 2016-11-04
$2.49M
10-Q · filed 2015-11-16
$2.80M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$849.00K
10-Q · filed 2016-08-08
$848.76K
10-Q · filed 2015-08-05
$1.90M
10-Q · filed 2016-08-08
$1.90M
10-Q · filed 2015-08-05
$2.21M
derived: sum of 3 quarters · filed 2017-03-16
$3.63M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$1.05K
10-Q · filed 2016-05-06
$1.05M
10-Q · filed 2015-05-15
$1.36M
derived: sum of 2 quarters · filed 2017-03-16
$2.78M
derived: sum of 3 quarters · filed 2017-03-16
$4.00M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$2.78M
derived: sum of 2 quarters · filed 2017-03-16
$4.00M
derived: sum of 3 quarters · filed 2017-03-16
$5.04M
10-K · filed 2017-03-16
2014-09-30$1.42M
10-Q · filed 2015-11-16
$2.64M
derived: sum of 2 quarters · filed 2015-11-16
$3.68M
10-Q · filed 2015-11-16
2014-06-30$1.22M
10-Q · filed 2015-08-05
$2.26M
10-Q · filed 2015-08-05
2014-03-31$1.04M
10-Q · filed 2015-05-15
2013-12-31$3.25M
10-K · filed 2016-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
EDAP TMS SA (FOCL)$0.171B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B